Transcatheter closure of atrial septal defect and patent foramen ovale in adult patients using the Amplatzer occlusion device: No evidence for thrombus deposition with antiplatelet agents
Authors:
- Roland R. BrandtRBRoland R. Brandt
- Thomas NeumannTNThomas Neumann
- Jörg NeuznerJNJörg Neuzner
- Matthias RauMRMatthias Rau
- Ingrid FaudeIFIngrid Faude
- Christian W. HammCHChristian W. Hamm
- 1 October 2002
- journal article
- Published by Elsevier in Journal of the American Society of Echocardiography
- Vol. 15 (10) , 1094-1098
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Percutaneous Closure of Patent Foramen Ovale in Patients With Paradoxical EmbolismCirculation, 2000
- Transcatheter closure of secundum atrial septal defects with the new self-centering Amplatzer Septal OccluderEuropean Heart Journal, 1999
- Surgical Closure of Patent Foramen Ovale in Cryptogenic Stroke PatientsStroke, 1997
- Transvenous Closure of Secundum Atrial Septal DefectsCirculation, 1997
- Identification of patent foramen ovale permitting paradoxic embolismJACC, 1995
- A Comparison of Surgical and Medical Therapy for Atrial Septal Defect in AdultsNew England Journal of Medicine, 1995
- Peri-operative complications following surgical closure of atrial septal defect type II in 232 patients—a baseline studyEuropean Heart Journal, 1994
- Risk of patent foramen ovale for thromboembolic events in all age groupsThe American Journal of Cardiology, 1992
- Long-Term Outcome after Surgical Repair of Isolated Atrial Septal DefectNew England Journal of Medicine, 1990
- Incidence and Size of Patent Foramen Ovale During the First 10 Decades of Life: An Autopsy Study of 965 Normal HeartsMayo Clinic Proceedings, 1984